Skip to content
Lower risk Medical device recall · FDA · Published September 20, 2021

Siemens Advia UCFP Reagent May Cause False Low A1c Results

Siemens Healthcare recalls Advia UCFP reagents that may produce falsely low hemoglobin A1c results, affecting diabetes management decisions. Affected lots are identified by serial number.

🇺🇸 FDA recall #Z-0181-2022Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics, Inc.511 Benedict Ave · Tarrytown, NY 10591-5005
✎ GovInfoNow plain-language explainer

Siemens Healthcare is recalling Advia Chemistry Urinary/Cerebrospinal Fluid Protein reagents that could cause false low hemoglobin A:1c test results. This might lead to incorrect diabetes treatment decisions if the test results are used without correction. Read more at govinfonow.com/recall/61790-siemens-advia-ucfp-reagent-may-cause-false-low-a1c-results.

Source Summary by GovInfoNow · govinfonow.com/recall/61790-siemens-advia-ucfp-reagent-may-cause-false-low-a1c-results · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0181-2022

Cite this page

“Siemens Advia UCFP Reagent May Cause False Low A1c Results.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61790-siemens-advia-ucfp-reagent-may-cause-false-low-a1c-results. Based on FDA recall #Z-0181-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0181-2022%22&limit=1).

The FDA announced on Sept. 20, 2021, that Siemens Healthcare Diagnostics is recalling Advia Chemistry Urinary/Cerebrospinal Fluid Protein reagent due to potential carryover affecting Enzymatic Hemoglobin A1c results. The agency issued recall number Z-0181-2022 for the voluntary Class II action.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: Advia Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP)
  • Model/Series Number: SMN 11319151
  • Lot codes: All lots impacted

The hazard

The firm confirmed the potential for reagent carryover impacting Enzymatic Hemoglobin A1c (A1c_E and A1c_EM) results. Falsely depressed Enzymatic Hemoglobin A1c results may affect consideration of intervention.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics, Inc. has 150 other recalls on record since June 7, 2017. Recent similar recalls include the Siemens Atellica CH RCRP Test recall (Aug. 17, 2026) and the Siemens Healthcare Syva EMIT 2000 Quinidine Assay Recall (July 13, 2026). Other recent recalls of similar products include the Abbott Diabetes Care FreeStyle Libre 3 Plus Sensor Recall (Nov. 24, 2025) and the Fujirebio Lumipulse pTau 217 Plasma Controls Recall (Dec. 11, 2025).

How to tell if you have this one

Check the serial number on the reagent vial. The affected product is labeled as Advia Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP) with serial number SMN 11319151.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Worldwide distribution - US Nationwide distribution.
Recall numberProduct, codes & lotsQuantity
Z-0180-2022Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP), SMN 11097543; All lots impacted1402 (US); 2941 (OUS)
Z-0181-2022Advia Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP), SMN 11319151; All lots impacted246 (US); 689 (OUS)
Based on the official FDA remedy

What to do — step by step

  1. Check Reagent Serial Number

    Look for the serial number SMN 11319151 on the Advia UCFP reagent vial.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 44 days after the firm started it.

1. Firm started the recall: Sep 20, 202112. FDA classified it Class II: Oct 28, 202123. Published in FDA’s Enforcement Report: Nov 3, 202132021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury?

No serious injury risk is described in the recall notice. The hazard is related to test results, not physical harm.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0181-2022 (September 20, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0181-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA